Global Intra-uterine Contraceptive Devices (IUCD) Market, 2017-2024 - Increasing Demand for Generic and Biosimilar Drugs

In this region, global intra-uterine contraceptive devices market is projected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024.
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

In this region, global intra-uterine contraceptive devices market is projected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024.

The global intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

The global intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Market Overview

Drivers

Restraints

Opportunity

Challenges

Global intra-uterine contraceptive devices (IUCD) market competition by top players including:

Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include:

Key Topics Covered:

1. Introduction

2. Market Segmentation

3. Market Overview

4. Executive Summary

5. Premium Insights

6. Global Injectable Drug Delivery Market, Regulatory

7. Global Injectable Drug Delivery Market, by Type

8. Global Injectable Drug Delivery Market, by Application

9. Global Injectable Drug Delivery Market, by Usage Pattern

10. Global Injectable Drug Delivery Market, by Mode of Administration

11. Global Injectable Drug Delivery Market, by End User

12. Global Injectable Drug Delivery Market, by Distribution Channel

13. Global Injectable Drug Delivery Market, by Geography

14. Global Injectable Drug Delivery Market, Company Share

15. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/v5l825/global_iucd

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Per maggiori informazioni

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;